Bioxytran announces Springer book linking hyperbaric oxygenation to BXT-25 drug

BIOXYTRAN, INC

Book by Prof. Mayevsky published by Springer; covers hyperbaric oxygenation and mitochondrial activity.
BXT-25 is an acellular oxygen carrier (AOC) 5,000x smaller than RBC; aims to replace HBOT.
MDX Viewer (FDA-approved) measures tissue oxygenation via Brain Metabolic Score (BMS).
BMS used as biomarker to demonstrate efficacy in upcoming stroke and Alzheimer's trials.
Company expects coupling BXT-25 with MDX Viewer could shorten clinical trial timelines.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.